What’s the next big frontier in pharmaceutical marketing? Blockbuster drugs seem harder to develop these days, and it’s getting more difficult to sell minor tweaks to old products as major breakthroughs. It’s even getting more challenging to talk to physicians, as many of the old ploys to get face time (expensive meals, honoraria, etc.) are being abandoned. These days, it seems, pharma companies have been reduced to trying to convince consumers they suffer from obscure maladies like “restless leg syndrome.” The Holy Grail of new products would be a drug that could be used by anyone, and that is so attractive that consumers will flock to their physicians to demand it. Could that drug be a cognitive enhancer? Enter the brave new world of cosmetic neurology… […]